Halt to K Phase 1 trial and announcement of a meeting with FDA with details pending. Where would that takes us? Have always felt that K is so safe that we may reaching a tipping point where evidence of efficacy looks strong with no MTD in sight. At that point I think a meeting with the FDA on how to proceed would be in order. My prayer.
Market Data 
Markets 
AI
